<DOC>
	<DOCNO>NCT00132236</DOCNO>
	<brief_summary>This smoking cessation study COPD patient researcher want evaluate nicotine sublingual tablet placebo combine low high individual support could increase ½ 1 year quit rate .</brief_summary>
	<brief_title>Nurse Smoking Cessation Patients With Chronic Obstructive Pulmonary Disease ( COPD ) With Nicotine Replacement Therapy ( NRT ) Behavioral Support</brief_title>
	<detailed_description>Placebo , control , randomize , double-blind trial 400-1000 smoking COPD patient FEV-1 &lt; 90 % predict normal use nicotine sublingual nicotine tablet placebo 12 week combine individual clinic visit low high intensity conduct trained nurse several centre pulmonary clinic Denmark . Outcome smoke cessation smoking reduction ½ 1 year self declare smoking status confirm carbon monoxide expire air &lt; 10 ppm . Secondary outcome change body-weight , quality life ( SF-36 SGRQ ) , symptom , lung function , adverse event .</detailed_description>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>COPD patient ( FEV1/FVC &lt; 70 % FEV1 &lt; 90 % predict ) Smoking 1 cigarette daily Willing follow protocol Used NRT bupropion last week Not able willing adhere protocol Estimated survival &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>smoke cessation</keyword>
	<keyword>nicotine sublingual tablet</keyword>
	<keyword>behaviour support</keyword>
	<keyword>smoke reduction</keyword>
	<keyword>quality life</keyword>
	<keyword>COPD</keyword>
	<keyword>weight</keyword>
</DOC>